Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories

被引:155
作者
Lippi, Giuseppe [1 ]
Plebani, Mario [2 ]
Di Somma, Salvatore [3 ]
Cervellin, Gianfranco [4 ]
机构
[1] Azienda Osped Univ Parma, UO Diagnost Ematochim, I-43100 Parma, Italy
[2] Azienda Osped Univ Parma, UO Pronto Soccorso & Med Urgenza, I-43100 Parma, Italy
[3] Univ Roma La Sapienza, Osped St Andrea, Dipartimento Med Emergenza, Rome, Italy
[4] Univ Padua, Dipartimento Med Lab, Padua, Italy
关键词
hemolysis; hemolyzed specimens; laboratory testing; hemolytic anemia; THROMBOCYTOPENIC PURPURA; OXYGEN CARRIER; SAMPLES DRAWN; BLOOD-SAMPLES; HEMOGLOBIN; ANEMIA; HAPTOGLOBIN; DIAGNOSIS; INTERFERENCE; PREVALENCE;
D O I
10.3109/10408363.2011.600228
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The term hemolysis designates the pathological process of breakdown of red blood cells in blood, which is typically accompanied by varying degrees of red tinge in serum or plasma once the whole blood specimen has been centrifuged. Hemolyzed specimens are a rather frequent occurrence in laboratory practice, and the rate of hemolysis is remarkably higher in specimens obtained in the Emergency Department (ED) as compared with other wards or outpatient phlebotomy services. Although hemolyzed specimens may reflect the presence of hemolytic anemia, in most cases they are due to preanalytical sources related to incorrect procedures or failure to follow procedures for collection, handling and storage of the samples; some of these are typical of the ED. Since hemolyzed specimens are often an important cause of relationship, economic, organizational and clinical problems between the ED and the clinical laboratory, it is essential to develop effective processes for systematically identifying unsuitable specimens (e. g. by using the hemolysis index), differentiating in vitro from in vivo hemolysis, troubleshooting the potential causes, and maintaining good relations between the clinical laboratory and the ED.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 56 条
[1]  
[Anonymous], EJIFCC
[2]   Paroxysmal nocturnal hemoglobinuria: Insights from recent advances in molecular biology [J].
Bessler, M ;
Schaefer, A ;
Keller, P .
TRANSFUSION MEDICINE REVIEWS, 2001, 15 (04) :255-267
[3]   G6PD: Population genetics and clinical manifestations [J].
Beutler, E .
BLOOD REVIEWS, 1996, 10 (01) :45-52
[4]  
Beutler E, 1995, WILLIAMS HEMATOLOGY, P674
[5]  
BEUTLER E, 1995, WILLIAMS HEMATOLOGY, P670
[6]   Guidelines for the diagnosis and management of hereditary spherocytosis [J].
Bolton-Maggs, PHB ;
Stevens, RF ;
Dodd, NJ ;
Lamont, G ;
Tittensor, P ;
King, MJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (04) :455-474
[7]   Hemolysis in serum samples drawn by emergency department personnel versus laboratory phlebotomists [J].
Burns, ER ;
Yoshikawa, N .
LABORATORY MEDICINE, 2002, 33 (05) :378-380
[8]   Interference in clinical chemistry assays by the hemoglobin-based oxygen carrier, Hemospan® [J].
Cameron, Scott J. ;
Gerhardt, Gregory ;
Engelstad, Michael ;
Young, Mark A. ;
Norris, Edward J. ;
Sokoll, Lori J. .
CLINICAL BIOCHEMISTRY, 2009, 42 (03) :221-224
[9]  
Carraro P, 2000, CLIN CHEM, V46, P306
[10]   Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus Infection [J].
Chiao, Elizabeth Y. ;
Engels, Eric A. ;
Kramer, Jennifer R. ;
Pietz, Kenneth ;
Henderson, Louise ;
Giordano, Thomas P. ;
Landgren, Ola .
ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (04) :357-363